| 6.3 Analysis on purchase decision factors |
| 6.2 Analysis on ranking of purchase of dermatologic topical medicines |
| Ⅶ Analysis on competition |
| 7.1 Xian’an Yangsen |
| 7.1.1 Company’s survey |
| 阅读全文：https://www.20087.com/2007-07/R_nalysiseportonorecastandnvestmentofhBaoGao.html |
| 7.1.2 Strict management and encouragement-orientation |
| 7.1.3 Team construction |
| 7.1.4 Personalized working environment |
| 7.1.5 Enhancing patriotic and traditional education |
| 7.2 Zhongmei Shike |
| 7.2.1 Company’s survey |
| 7.2.2 Facing challenge |
| 7.2.3 Choosing process |
| 7.2.4 Implementing effect |
| 7.2.5 Diagnosis |
| Analysis Report on Forecast and Investment of China Skin Medication Industry |
| 7.3 Sanjiu Hospital |
| 7.3.1 Company’s survey |
| 7.3.2 Strategy of hospital and hospital’s trade |
| 7.3.3 5s Management |
| 7.4 Shanghai Johnson |
| 7.4.1 Company’s survey |
| 7.4.2 Non-typical exclusive capital |
| Analysis Report on Forecast and Investment of China Skin Medication Industry |
| 7.5 Dihon Pharmaceutical Company |
| 7.5.1 Company’s survey |
| 7.5.2 Human orientation； Strengthening medicine with technology |
| 7.5.3 To develop with “two short and one length’ |
| 7.6 Jiannan Dongfeng Pharmaceutical Company |
| 7.7 Beijing Nuohua |
| 7.7.1 Company’s survey |
| 7.7.2 To compete in non-patent medicine |
| 7.7.3 New products |
| analysis report on forecast and investment of china skin medication industry |
| 7.8 MERCK China |
| 7.9 Guangdong Shunde Shunfeng Pharmaceutical Company |
| 7.9.1 Company’s survey |
| 7.9.2 Technology of scientific research |
| 7.10 Shanghai Xianling Baoya Pharmaceutical Company |
| 7.11 Tianjin Pharmaceutical Company |
| 7.11.1 Company’s survey |
| 7.11.2 Company spirit |
| 7.11.3 Strategy |
| 中国スキン薬産業の予測と投資分析レポート |
| 7.11.4 Whys of reform |
| 7.12 Guangzhou Hegong Parmaceutical Company |
| 7.12.1 Company’s survey |
| 7.12.2 Developing plan |
| Ⅷ Analysis on developing trend |
| 8.1 Focuses and prospect of research |
| 8.2 Forecast on market size |
略……
京公网安备 11010802027459号